3 Women Healthcare Stocks With Solid Growth Potential Amid COVID-19Zacks Investment Research • 04/09/21
Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing LeadersGlobeNewsWire • 03/29/21
Myriad Genetics Receives Additional Reimbursement for myChoice® Diagnostic System in JapanGlobeNewsWire • 03/24/21
MYRIAD GENETICS ALERT: Bragar Eagel & Squire, P.C. Announces the Shareholder Class Action Against Myriad Genetics, Inc. Survives Motion to Dismiss and Encourages Long-term Investors to Contact the FirmBusiness Wire • 03/24/21
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing ServicesGlobeNewsWire • 03/02/21
Myriad Genetics, Inc. (MYGN) CEO Paul Diaz on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/21
Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation PlanGlobeNewsWire • 02/23/21
Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth InitiativesGlobeNewsWire • 02/18/21
Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021GlobeNewsWire • 02/16/21
New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics' Prolaris® test to Guide Treatment for Prostate CancerGlobeNewsWire • 02/12/21
Myriad Genetics to Participate in Multiple Upcoming Health and Technology ConferencesGlobeNewsWire • 02/11/21
GeneSight Psychotropic Test's Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood LevelsGlobeNewsWire • 02/08/21
Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid ArthritisGlobeNewsWire • 02/02/21
Earnings Preview: Myriad Genetics (MYGN) Q2 Earnings Expected to DeclineZacks Investment Research • 01/28/21
Myriad Genetics Receives Reimbursement for BRACAnalysis® Diagnostic System in JapanGlobeNewsWire • 01/19/21
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Myriad Genetics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of DirectorsPRNewsWire • 01/18/21